Page 14 - ANTIFUNGAL SUSCEPTIBILITY OF CLINICAL YEAST ISOLATES 2018-2020

The antifungal susceptibility patterns and percentages are shown in Table
2.3. and Figure 2.1.

Table 2.3: Antifungal susceptibility patterns & percentages of C. parapsilosis complex.
Antifungal Percentage (n) of isolates
agents
S I R WT NWT

Anidulafungin 36.6% (45) 24.4% (30) 39.0% (48)

Caspofungin 58.3% (77) 28.8% (38) 12.9% (17)

Micafungin 91.7% (33) 8.3% (3) 0% (0)

Voriconazole 90.0% (117) 10.0% (13) 0.0% (0)

Fluconazole 83% (112) 5.9% (8) 11.1% (15)

Posaconazole 77.8% (7) 22.2% (2)

Amphotericin 98.5% (128) 1.5% (2)
B

Figure 2.1: Antifungal susceptibility patterns of C. parapsilosis complex against
7 antifungal agents in 2018-2020.
Antifungal susceptibility patterns

120%

100%

Percentage (%) 80%

60%

40%

20%

0%
Anidulafungin Caspofungin Micafungin Voriconazole Fluconazole Posaconazole Amphotericin
B
Antifungals

S I R WT NWT

14 |